CN
CN
Our latest
Creative Biosciences
Creative Biosciences Releases Annual Real-World Application Data from Over 1.29 Million Colosafe® Tests

January 12, 2026, Guangzhou, China, Creative Biosciences, a leader in fecal DNA–based colorectal cancer screening in China, has released its annual update of real-world application data for Colosafe, the company’s proprietary early colorectal cancer screen

Jan 12 , 2026
Media Coverage
Authoritative media releases


Read more
Press releases
Creative Biosciences Releases Annual Real-World Application Data from Over 1.29 Million Colosafe® Tests
Jan 12 , 2026
Lunsafe® Wins NMPA Approval, Pioneering Noninvasive Early Detection of Lung Cancer in China
Jun 01 , 2025
Creative Biosciences Expands in Latin America, Bringing Colosafe® Closer to Local Communities for Early Cancer Detection
Nov 02 , 2025
Creativebio Made Debut Presence at Life Science Innovation Northwest 2025
May 06 , 2025
Creative Biosciences Expands Global Footprint with New Seattle Branch
Mar 21 , 2025
One Million Tests of Colosafe Realized in Real World Practice
Feb 20 , 2025
CreativeBio Is Exhibiting at MEDICA 2022
Nov 15 , 2022
Colosafe® Gained Market Entry in Mexico
Jan 23 , 2025
CreativeBio,the Leading Enterprise in Cancer Screening,Completed Rd D Venture Capital Financing of RMB 560 Million Led by Alibaba
Oct 20 , 2021
Creative Biosciences Shines at MEDICA 2024 in Germany, Accelerating Its Global Market Expansion
Nov 14 , 2024
Colosafe Was Showcased at the 46th Mexican National Clinical Chemists Conference in Mecixo City
Sep 15 , 2024
Colosafe® Showcased in the National "13th Five-Year" Scientific and Technical Innovation Achievement Exhibition
Nov 02 , 2021

No. 10 Fenghuang Wu Road
Huangpu District
Guangzhou, Guangdong, 510555
P.R. China


Contact us at

T: +001-206-717-2769
Email: info@creativebio.cn


copyright ©2025 Creative Biosciences (Guangzhou) CO., Ltd
Legal mention